To examine whether the REV-ERBα, FOXA1, and BRD4 regulatory axis plays a function in vivo in control of tumorigenic gene programs, we first performed FOXA1 and REV-ERBα ChIP-seq analysis with a PDX tumor model (38, 39). The gene discussed is FOXA1; the disease is neoplasm.